Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-06 |
mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.23 | 4e-06 |
mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-06 |
mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.18 | 0.0004 |
mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.84 | 0.0006 |
mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0009 |
mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |